Understanding what happens to therapeutic antibodies and antibody-drug conjugates (ADCs) after they enter a cell is critical to designing targeted […]
The Newsroom
News
No matching results found
Sai Life Sciences plans to set up a new oral solid formulation facility to support small-molecule programs entering early clinical […]
27 Aug 2026
We have successfully scaled up a late-stage GMP intermediate for a large pharmaceutical customer using flow chemistry, marking another step […]
20 Aug 2026
A recent publication from Sai Life Sciences highlights our work on a three-dimensional hepatic spheroid-array system for the assessment of […]
18 Aug 2026
Sai Life Sciences is seeing increasing opportunities to deepen and expand customer relationships through dedicated Full-Time Equivalent (FTE) engagement models, […]
14 Aug 2026
Sai Life Sciences has inaugurated the first facility within its new Unit VIII campus in Hyderabad’s Genome Valley, marking an […]
10 Aug 2026
Hyderabad, August 06, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, […]
7 Aug 2026
Under monsoon skies, a group of Saimers set out to uncover the story behind Kudikunta Lake’s revival—starting where few people […]
19 Jul 2026
Sai Life Sciences’ R&D and manufacturing units—Unit 2 and Unit 4—in India have been awarded the Zero Waste to Landfill […]
7 Jul 2026
Hyderabad, June 25, 2026:Sai Life Sciences (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing, innovator-focused Contract Research, Development […]
25 Jun 2026
Hyderabad, June 16, 2026:Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development, […]
16 Jun 2026
Understanding what happens to therapeutic antibodies and antibody-drug conjugates (ADCs) after they enter a cell is critical to designing targeted […]
2 Sep 2026
Sai Life Sciences plans to set up a new oral solid formulation facility to support small-molecule programs entering early clinical […]
27 Aug 2026
We have successfully scaled up a late-stage GMP intermediate for a large pharmaceutical customer using flow chemistry, marking another step […]
20 Aug 2026
A recent publication from Sai Life Sciences highlights our work on a three-dimensional hepatic spheroid-array system for the assessment of […]
18 Aug 2026
Sai Life Sciences is seeing increasing opportunities to deepen and expand customer relationships through dedicated Full-Time Equivalent (FTE) engagement models, […]